News

X-ZELL Global HQ now open for business

Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between Changi Airport and the city's vibrant Central Business...

X-ZELL shortlisted for 2019 HealthInvestor Asia Award

Singapore, April 2019 – Rare cell detection specialist, X-ZELL, has been shortlisted as a Finalist for the 2019 HealthInvestor Asia Awards. According to HealthInvestor Asia, X-ZELL has been nominated in the “Diagnostics Deal of the Year” category following the signing...

X-ZELL welcomes new Brand Ambassadors

Singapore, February 2019 – In a move to support the forthcoming world premiere of the X-ZELL Cryoimmunostaining™ Suite, X-ZELL is proud to announce the appointment of Heinz Hildebrand and Troy Bailey as the company’s new Brand Ambassadors. Heinz Hildebrand will...

Global launch of X-ZELL Cryoimmunostaining™ Suite confirmed

Singapore, February 2019 – Rare cell detection specialist X-ZELL has officially confirmed the launch of the world’s first 9-colour immunostaining system. Originally designed to enable the company’s headline-making research into next-generation biomarkers, the...

X-ZELL signs research collaboration agreement with DxD Hub

X-ZELL is now officially partnering with Singapore’s DxD Hub.   Singapore, December 2018 – In a move that will accelerate the company's capabilities and scale up its commercialisation and product development processes, X-ZELL Inc. has partnered with Singapore’s...

X-ZELL CEO presenting breakthrough CEC research at EMUC18

Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has used the 2018 European Multidisciplinary Congress on Urological Cancers (EMUC18) in Amsterdam as a platform to present new insights into the origin and clinical utility of Circulating Endothelial Cells...

X-ZELL taking centre stage at inaugural A*CCELERATE NOW expo

Singapore, November 2018 – X-ZELL Inc. has been one of eight promising biotechnology start-ups selected to exhibit at the inaugural A*CCELERATE NOW exhibition in Singapore. The landmark event – held in a move to celebrate the re-branding of ETPL, the commercialisation...

X-ZELL CEO to present at EMUC18 in Amsterdam

Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has been invited to join the 2018 European Multidisciplinary Congress on Urological Cancers (#EMUC18) in Amsterdam next month as a plenary speaker. Dr Bhakdi’s addition to the Congress’ high-profile program...

X-ZELL technology suite upgrade underway

Singapore, October 2018 – Cancer detection specialist, X-ZELL Inc., has announced a new version of the company’s world-unique Cryoimmunostaining™ suite. Whilst keeping details close to his chest, X-ZELL’s Head of Engineering & QA, Bart Van der Voort, revealed that...

X-ZELL Global HQ now open for business

Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between Changi Airport and the city's vibrant Central Business...

X-ZELL shortlisted for 2019 HealthInvestor Asia Award

Singapore, April 2019 – Rare cell detection specialist, X-ZELL, has been shortlisted as a Finalist for the 2019 HealthInvestor Asia Awards. According to HealthInvestor Asia, X-ZELL has been nominated in the “Diagnostics Deal of the Year” category following the signing...

X-ZELL welcomes new Brand Ambassadors

Singapore, February 2019 – In a move to support the forthcoming world premiere of the X-ZELL Cryoimmunostaining™ Suite, X-ZELL is proud to announce the appointment of Heinz Hildebrand and Troy Bailey as the company’s new Brand Ambassadors. Heinz Hildebrand will...

X-ZELL CEO to present at EMUC18 in Amsterdam

Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has been invited to join the 2018 European Multidisciplinary Congress on Urological Cancers (#EMUC18) in Amsterdam next month as a plenary speaker. Dr Bhakdi’s addition to the Congress’ high-profile program...

X-ZELL technology suite upgrade underway

Singapore, October 2018 – Cancer detection specialist, X-ZELL Inc., has announced a new version of the company’s world-unique Cryoimmunostaining™ suite. Whilst keeping details close to his chest, X-ZELL’s Head of Engineering & QA, Bart Van der Voort, revealed that...

X-ZELL

FIGHTING CANCER,
ONE CELL AT A TIME.

© 2019 X-ZELL INC

Find Us

XZELL HQ